البحث | Webyourself Social Media Platform

أضاف مادة جديدة Health

2024-05-30 07:20:46 -

PARP Inhibitor Biomarkers Market Is Driven By Increasing Prevalence Of Cancer

The PARP inhibitor biomarkers market involves the use of biomarkers to detect PARP inhibitors which are a class of targeted therapy approved for the treatment of cancers like ovarian cancer and breast cancer. PARP inhibitors work by blocking an enzyme called poly (ADP-ribose) polymerase or PARP which is involved in DNA repair. When PARP is blocked, DNA damage caused by chemotherapy or radiation...

0 التعليقات 0 المشاركات 586 مشاهدة 0 معاينة